Painel — Diário Oficial de Canindé

Editar publicação

Edição

Secretaria

Tipo (opcional)

Ordem (nº dentro da Secretaria)

Título (opcional)

Ementa (opcional)

Conteúdo (use o editor; tabelas são preservadas)

AVISO DE HOMOLOGAÇÃO E ADJUDICAÇÃO<o:p></o:p>
PROCESSO ADMINISTRATIVO Nº 20251031001-ADM<o:p></o:p>
CREDENCIAMENTO Nº 2025121001-CRED<o:p></o:p>
A Secretária Executiva do Consórcio Público de Saúde da Microrregião de Canindé, no uso de suas atribuições conferidas por Lei e, considerando o resultado apresentado pela Comissão de Contratação do Consórcio Público de Saúde da Microrregião de Canindé, referente ao Credenciamento <a name="_Hlk124406068"></a>Nº 2025121001-CRED, cujo objeto é a CHAMAMENTO PÚBLICO PARA CREDENCIAMENTO VISANDO CONTRATAÇÃO DE PRESTAÇÃO DE SERVIÇOS DE EXAMES LABORATORIAIS E CITOPATOLÓGICOS, DESTINADO AO ATENDIMENTO DA DEMANDA GERADA PELA POLICLÍNICA REGIONAL FREI LUCAS DOLLE, VINCULADA AO CONSÓRCIO PÚBLICO DE SAÚDE DA MICRORREGIÃO DE CANINDÉ-CPSMCA. Considerando que o processo se encontra em conformidade com as normas legais.<o:p></o:p>
<o:p> </o:p>
Torna público que, ADJUDICOU e HOMOLOGOU o processo de Credenciamento Nº 2025121001-CRED, ao seguinte proponente em seus respectivos itens:<o:p></o:p>
<a name="_Hlk149117502"></a><o:p> </o:p>
<a name="_Hlk205279928"></a>Licitante:<a name="_Hlk137719333"></a> LABORATÓRIO DE ANÁLISES CLÍNICAS HOMELAB LTDA, inscrita no CNPJ sob o Nº 17.620.339/0001-93, com valor Global: R$ 485.513,00 (quatrocentos e oitenta e cinco mil quinhentos e treze reais), conforme itens:<o:p></o:p>
<o:p> </o:p>
<div align="center">
<table class="MsoNormalTable" border="1" cellspacing="0" cellpadding="0" width="0" style="width: 495.9pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 3.5pt 0cm 3.5pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext;">
<tbody>
<tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 4.3pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 4.3pt;">
ITEM<o:p></o:p>
</td>
<td width="327" nowrap="nowrap" style="width: 245.55pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 4.3pt;">
DESCRIÇÃO<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 4.3pt;">
QUANT.<o:p></o:p>
</td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 4.3pt;">
UNIDADE<o:p></o:p>
</td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 4.3pt;">
VR. UNIT (R$)<o:p></o:p>
</td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 4.3pt;">
VR. TOTAL (R$)<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.012-0 - DOSAGEM DE ACIDO URICO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
555,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.012-0 - DOSAGEM DE ACIDO URICO A DOSAGEM DO ACIDO ÚRICO É ÚTIL NA AVALIAÇÃO DO METABOLISMO DAS PURINAS. ENCONTRA-SE ALTERADO EM DIVERSAS CONDIÇÕES CLINICO-PATOLÓGICAS COMO, POR EXEMPLO, A GOTA. UTILIZADO TAMBÉM PARA MONITORAR PACIENTES EM QUIMIOTERAPIA OU RADIOTERAPIA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 3; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.008-0 - DOSAGEM DE ADRENOCORTICOTROFICO (ACTH)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
14,12<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.059,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 4; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.008-0 - DOSAGEM DE ADRENOCORTICOTROFICO (ACTH) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR O HORMÔNIO ADRENOCORTICOTRÓFICO, HORMÔNIO HIPOFISÁRIO ESTIMULADOR DA ATIVIDADE ENZIMÁTICA GLANDULAR.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 5; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.009-8 - DOSAGEM DE ALDOSTERONA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11,89<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
891,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 6; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.009-8 - DOSAGEM DE ALDOSTERONA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR ALDOSTERONA, PRINCIPAL MINERALOCORTICOIDE PRODUZIDO PELO CÓRTEX DA SUPRA-RENAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 7; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.004-7 - DOSAGEM DE 17-ALFA-HIDROXIPROGESTERONA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,20<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
459,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 8; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.004-7 - DOSAGEM DE 17-ALFA-HIDROXIPROGESTERONA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR 17-OH-PROGESTERONA, QUE É UM ESTERÓIDE PRODUZIDO PELAS GÔNODAS E PELAS SUPRA-RENAIS, PRECURSOR DA SÍNTESE DO CORTISOL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 9; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.065-1 - DOSAGEM DE TRANSAMINASE GLUTAMICO-PIRUVICA (TGP)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
900,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,01<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.809,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 10; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.065-1 - DOSAGEM DE TRANSAMINASE GLUTAMICO-PIRUVICA (TGP) A TRANSAMINASE GLUTAMICO-PIRUVICA É ENCONTRADA, PRINCIPALMENTE, NO FÍGADO. A DOSAGEM DE TRANSAMINASE GLUTAMICO-PIRUVICA É ÚTIL NA AVALIAÇÃO DE HEPATOPATIAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 11; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
6<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.018-0 - DOSAGEM DE AMILASE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
120,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,25<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
270,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 12; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROEDIMENTO: 02.02.01.018-0 - DOSAGEM DE AMILASE A AMILASE É HIDROLASE QUE DEGRADA COMPLEXOS DE CARBOIDRATOS, SENDO, PREDOMINANTEMENTE, DE ORIGEM PANCRÁTICA E GLÂNDULA SALIVAR. A DETERMINAÇÃO DA SUA DOSAGEM ESTÁ INDICADA NO DIAGNÓSTICO DIFERENCIAL DO QUADRO DE ABDOME AGUDO, ESPECIALMENTE, NA PANCREATITE AGUDA E NOS CASOS DE PAROTIDITE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 13; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
7<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.034-2 - PESQUISA DE ANTICORPOS ANTI-SM<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.287,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 14; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.034-2 - PESQUISA DE ANTICORPOS ANTI-SM CONSISTE EM UM TESTE IMUNOENZIMÁTICO, PARA DETECTAR A PRESENÇA DE ANTICORPO DIRECIONADO PARA RIBONUCLEOPROTEÍNAS DE BAIXO PESO MOLECULAR NO SORO OU PLASMA. OS ANTICORPOS ANTI-SM SÃO ALTAMENTE ESPECÍFICOS PARA O DIAGNÓSTICO DE LES.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 15; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
8<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.025-3 - PESQUISA DE ANTICORPO IGG ANTICARDIOLIPINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
450,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 16; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.025-3 - PESQUISA DE ANTICORPO IGG ANTICARDIOLIPINA CONSISTE NA PESQUISA DE ANTICORPO IGG ANTICARDIOLIPINA, QUE SÃO AUTO-ANTICORPOS DIRECIONADOS CONTRA FOSFOLIPÍDEOS ANIÔNICOS OU FOSFOLIPÍDEOS PROTÉICOS COMPLEXADOS, DA CLASSE DE ANTICORPOS RESPONSÁVEIS PELO PROCESSO DE COAGULAÇÃO PROLONGADO. UTILIZADO NO DIAGNÓSTICO DA SÍNDROME PRIMÁRIA OU SECUNDÁRIA DO ANTICORPO ANTIFOSFOLIPÍDEO, TROMBOCITOPENIAS E ABORTAMENTO DE REPETIÇÃO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 17; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
9<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.026-1 - PESQUISA DE ANTICORPO IGM ANTICARDIOLIPINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
60,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
600,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 18; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.026-1 - PESQUISA DE ANTICORPO IGM ANTICARDIOLIPINA CONSISTE NA PESQUISA DE ANTICORPO IGG OU IGM (???) ANTICARDIOLIPINA, QUE SÃO AUTO-ANTICORPOS DIRECIONADOS CONTRA FOSFOLIPÍDEOS ANIÔNICOS OU FOSFOLIPÍDEOS PROTEICOS COMPLEXADOS, DA CLASSE DE ANTICORPOS RESPONSÁVEIS PELO PROCESSO DE COAGULAÇÃO PROLONGADO. UTILIZADO NO DIAGNOSTICO DA SÍNDROME PRIMÁRIA OU SECUNDÁRIA DO ANTICORPO ANTIFOSFOLIPIDEO, TROMBOCITOPENIAS E ABORTAMENTO DE REPETIÇÃO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 19; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.029-6 - PESQUISA DE ANTICORPOS ANTI-HIV-1<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
85,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
12.750,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 20; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.029-6 - PESQUISA DE ANTICORPOS ANTI-HIV-1 (WESTERN BLOT/IMUNOBLOT) CONSISTE EM UMA TÉCNICA ANALÍTICA USADA PARA DETECTAR PROTEÍNAS ESPECÍFICAS EM UMA DADA AMOSTRA DE HOMOGENEIZADO DE TECIDO OU EXTRATO. UTILIZA ELETROFORESE EM GEL PARA SEPARAR AS PROTEÍNAS NATIVAS, QUE SÃO TRANSFERIDAS PARA UMA MEMBRANA DE NITROCELULOSE, UTILIZANDO ANTICORPOS ESPECÍFICOS PARA DETECÇÃO DA PROTEÍNA ALVO, INCLUINDO METADOLOGIAS AFINS (IMUNOBLOT/IMUNOBLOT RÁPIDO). INDICADO COMO TESTE CONFIRMATÓRIO, EM CASOS DE RESULTADO POSITIVO NO TESTE ELISA PARA HIV.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 21; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.118-7 - DOSAGEM DE ANTICORPOS ANTITRANSGLUTAMINAISE IGA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.782,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 22; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.118-7 - DOSAGEM DE ANTICORPOS ANTITRANSGLUTAMINAISE RECOMBINANTE HUMANO IGA DETECÇÃO QUANTITATIVA DO ANTICORPO ANTITRANSGLUTAMINASE DA CLASSE IGA POR ENSAIO IMUNOENZIMÁTICO, PARA O DIAGNÓSTICO E ACOMPANHAMENTO DA DOENÇA CELÍACA<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 23; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
12<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.02.057-6 - PESQUISA DE ANTICOAGULANTE LÚPICO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
60,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
110,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
6.600,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 24; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.02.057-6 - PESQUISA DE ANTICOAGULANTE LÚPICO CONSISTE NA APLICAÇÃO DE TÉCNICAS LABORATORIAIS A FIM DE PESQUISAR ANTICORPOS LÚPICOS COMO FORMA DE RASTREAMENTO DE TROMBOFILIA EM GESTANTES NOS SEGUINTES CASOS: (A) GESTANTES COM HISTÓRIA PESSOAL DE TEV, COM OU SEM FATOR DE RISCO RECORRENTE E SEM TESTE DE TROMBOFILIA PRÉVIO E (B) GESTANTES COM HISTÓRIA PRÉVIA DE ALTO RISCO DE TROMBOFILIA HEREDITÁRIA EM PARENTES DE PRIMEIRO GRAU.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 25; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
13<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.028-8 - PESQUISA DE ANTICORPOS ANTI-HELICOBACTER PYLORI<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.574,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 26; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.028-8 - PESQUISA DE ANTICORPOS ANTI-HELICOBACTER PYLORI CONSISTE NA PESQUISA PARA DETECÇÃO DE ANTICORPOS ANTI-HELICOBACTER PYLORI, QUE É UMA BACTÉRIA GRAM-NEGATIVA ESPIRAL MICROAERÓFILA. UTILIZADA NO DIAGNÓSTICO E ACOMPANHAMENTO DAS GASTRITES CRÔNICAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 27; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
14<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.062-8 - PESQUISA DE ANTICORPOS ANTITIREOGLOBULINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
225,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3.861,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 28; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.062-8 - PESQUISA DE ANTICORPOS ANTITIREOGLOBULINA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-TIREOGLOBULINA NO SORO. UTILIZADO NO DIAGNÓSTICO E ACOMPANHAMENTO DA TIREOIDITE DE HASHIMOTO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 29; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
15<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.047-4 - PESQUISA DE ANTICORPOS ANTIESTREPTOLISINA O (ASLO)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,83<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
849,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 30; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.047-4 - PESQUISA DE ANTICORPOS ANTIESTREPTOLISINA O (ASLO) CONSISTE NA PESQUISA DE ANTICORPO ANTIESTREPTOLISINA O, QUE É UMA PROTEÍNA DE CAPACIDADE HEMOLÍTICA, PRODUZIDA PELOS ESTREPTOCOCOS DO GRUPO A. UTILIZADO NO DIAGNÓSTICO E ACOMPANHAMENTO DE PROCESSOS INFECCIOSOS POR STREPTOCOCCUS DO GRUPO A, FEBRES REUMÁTICAS E GLOMERULONEFRITES AGUDA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 31; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
16<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.121-7 - DOSAGEM DO ANTÍGENO CA 125<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
13,35<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.002,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 32; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.121-7 - DOSAGEM DO ANTÍGENO CA 125 DOSAGEM SÉRICA DO MARCADOR CA 125 PARA ACOMPANHAMENTO DE DOENTES DE NEOPLASIA MALIGNA EPITELIAL DE OVÁRIO OU DE TROMPA UTERINA OU DE CARCINOMATOSE PERITONEAL SOB TRATAMENTO ANTINEOPLÁSICO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 33; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.055-5 - PESQUISA DE ANTICORPOS ANTIMICROSSOMAS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.287,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 34; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.055-5 - PESQUISA DE ANTICORPOS ANTIMICROSSOMAS<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 35; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.036-9 - PESQUISA DE ANTICORPOS ANTI-SS-B (LA)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
834,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 36; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.036-9 - PESQUISA DE ANTICORPOS ANTI-SS-B (LA) CONSISTE EM UM TESTE IMUNOENZIMÁTICO, PARA DETECTAR A PRESENÇA DE ANTICORPO DIRECIONADO PARA FOSFOPROTEÍNA COMPLEXADA A PEQUENOS RNAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 37; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
19<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.035-0 - PESQUISA DE ANTICORPOS ANTI-SS-A (RO)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
834,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 38; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.035-0 - PESQUISA DE ANTICORPOS ANTI-SS-A (RO) CONSISTE EM UM TESTE IMUNOENZIMÁTICO, PARA DETECTAR A PRESENÇA DE ANTICORPO DIRECIONADO CONTRA O ANTÍGENO RO, QUE É UMA RIBONUCLEOPROTEÍNA CONSTITUÍDA POR PEQUENOS ÁCIDOS NUCLEICO RICOS EM URIDINA. UTILIZADA NO DIAGNOSTICO DA SÍNDROME DE SJÖGREN, DOENÇAS REUMÁTICAS AUTOIMUNES E ALGUMAS FORMAS DE LES.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 39; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
20<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.064-3 - DOSAGEM DE TRANSAMINASE GLUTAMICO-OXALACETICA (TGO)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
750,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,01<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.507,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 40; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.064-3 - DOSAGEM DE TRANSAMINASE GLUTAMICO-OXALACETICA (TGO) A TRANSAMINASE GLUTAMICO-OXALACETICA É UMA ENZIMA ENCONTRADA EM ALTAS QUANTIDADES NO MÚSCULO CARDÍACO, ESQUELÉTICO, CÉLULAS HEPÁTICAS E, EM MENOR QUANTIDADE, NO PÂNCREAS E NOS RINS. A DOSAGEM DE TRANSAMINASE GLUTAMICO-OXALACETICA É ÚTIL, POR EXEMPLO, NO DIAGNÓSTICO DO INFARTO DO MIOCÁRDIO, DAS DOENÇAS HEPÁTICAS, DA PANCREATITE AGUDA, DA OPERAÇÃO CARDÍACA, DA CATETERIZAÇÃO CARDÍACA, DA DISTROFIA MUSCULAR, DA MONONUCLEOSE, DA DOENÇA RENAL AGUDAE DE CONVULSÕES RECENTES.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 41; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
21<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.021-7 - DOSAGEM DE GONADOTROFINA CORIONICA HUMANA (HCG, BETA HCG)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
7,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.177,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 42; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.021-7 - DOSAGEM DE GONADOTROFINA CORIONICA HUMANA (HCG, BETA HCG) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR GONADOTROFINA CORIÔNICA, HORMÔNIO GLICOPROTÉICO COMPOSTO DE SUBUNIDADES ALFA E BETA, PRODUZIDO PELAS CÉLULAS DO SINCICIOTROFOBLASTO DA PLACENTA E, TAMBÉM, SINTETIZADO POR OUTROS TECIDOS TUMORAIS. FREQUENTEMENTE UTILIZADO NA DETERMINAÇÃO DE GRAVIDEZ, TEM INDICAÇÃO NA IDENTIFICAÇÃO OU SEGUIMENTO DE NEOPLASIA TROFOBLÁSTICA GESTACIONAL (CORIOCARCINOMA, CARCINOMA EMBRIONAL, MOLA HIDATIFORME E OUTROS) E COMO MARCADOR BIOQUÍMICO DE TECIDOS TUMORAIS DE DIVERSOS TIPOS HISTOLÓGICOS, ESPECIALMENTE TUMORES TESTICULARES.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 43; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
22<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.020-1 - DOSAGEM DE BILIRRUBINA TOTAL E FRACOES<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,01<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
301,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 44; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.020-1 - DOSAGEM DE BILIRRUBINA TOTAL E FRACOES A DOSAGEM DE BILIRRUBINA TOTAL E FRAÇÕES É ÚTIL NA AVALIAÇÃO DE HEPATOPATIAS E DE QUADROS HEMOLÍTICOS, EM PARTICULAR, NA AVALIAÇÃO DA ICTERÍCIA DO RECÉM-NASCIDO<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 45; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
23<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.021-0 - DOSAGEM DE CALCIO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
555,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 46; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.021-0 - DOSAGEM DE CALCIO O CÁLCIO É ENCONTRADO NAS CARTILAGENS, DENTES E, PRINCIPALMENTE, NOS OSSOS. A DOSAGEM DE CÁLCIO É ÚTIL NO DIAGNÓSTICO DE DISTÚRBIOS DO METABOLISMO DE CÁLCIO E FÓSFORO, INCLUINDO DOENÇAS ÓSSEAS, NEFROLÓGICAS E NEOPLÁSICAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 47; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
24<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.012-8 - DOSAGEM DE CALCITONINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
14,38<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.157,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 48; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.012-8 - DOSAGEM DE CALCITONINA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR CALCITONINA, HORMÔNIO PRODUZIDO PELAS CÉLULAS C PARAFOLICULARES NA TIREÓIDE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 49; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
25<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.002-3 - DETERMINACAO DE CAPACIDADE DE FIXACAO DO FERRO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,01<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
301,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 50; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.002-3 - DETERMINACAO DE CAPACIDADE DE FIXACAO DO FERRO REPRESENTA A PORÇÃO TOTAL DE FERRO LIGADA À TRANSFERRINA. A CAPACIDADE TOTAL DE COMBINAÇÃO DO FERRO AUMENTA EM PATOLOGIAS QUE REDUZEM AS RESERVAS DE FERRO (DEFICIÊNCIA DO METAL OU PERDA SANGUÍNEA ), OU QUE ELEVAM A PRODUÇÃO HEPÁTICA DE TRANSFERRINA (GESTAÇÃO E USO DE ANTICONCEPCIONAL ORAL) A CAPACIDADE TOTAL DIMINUI NA PATOLOGIAS EM QUE A QUANTIDADE DE FERRO ESTA AUMENTADA, COMO NA HEMOCROMATOSE<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 51; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
26<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.074-1 - PESQUISA DE ANTICORPOS IGG ANTICITOMEGALOVIRUS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
825,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 52; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.074-1 - PESQUISA DE ANTICORPOS IGG ANTICITOMEGALOVIRUS CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS IGG NO SORO. O CITOMEGALOVÍRUS É UM DOS CAUSADORES MAIS COMUNS DE INFECÇÕES CONGÊNITAS, E TAMBÉM PROBLEMA COMUM EM RECEPTORES DE ÓRGÃOS E PACIENTES IMUNOSSUPRIMIDOS. A PRESENÇA DE IGG PODE INDICAR INFECÇÃO PASSADA OU RECENTE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 53; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
27<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.085-7 - PESQUISA DE ANTICORPOS IGM ANTICITOMEGALOVIRUS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11,61<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
870,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 54; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.085-7 - PESQUISA DE ANTICORPOS IGM ANTICITOMEGALOVIRUS CONSISTE EM UM TESTE IMUNOENZIMÁTICO, PARA DETECTAR A PRESENÇA DE ANTICORPOS DA CLASSE IGM. OS ANTICORPOS IGM APARECEM SEGUINDO A INFECÇÃO INICIAL E PERSISTEM POR 3 A 4 MESES. PODE INDICAR INFECÇÃO PRIMÁRIA E/OU REATIVAÇÃO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 55; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
28<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.05.002-5 - CLEARANCE DE CREATININA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,51<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
526,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 56; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.05.002-5 - CLEARANCE DE CREATININA É UM INDICE DA MASSA RENAL FUNCIONANTE E PERMITE UM DIAGNÓSTICO MAIS PRECOCE DE ALTERAÇÃO DA FUNÇÃO RENAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 57; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
29<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.026-0 - DOSAGEM DE CLORETO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
120,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
222,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 58; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.026-0 - DOSAGEM DE CLORETO A CERULOPLASMINA É UMA PROTEÍNA DE FASE AGUDA, PODENDO APRESENTAR NÍVEIS ELEVADOS EM TUMORES, INFLAMAÇÕES AGUDAS E CRÔNICAS. CERCA DE 95% DO COBRE PLASMÁTICO ESTÁ LIGADO À CERULOPLASMINA. A ATIVIDADE DESTA PROTEÍNA É AUMENTADA PELO USO DE ESTRÓGENOS E FENITOÍNA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 59; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
30<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.02.049-5 - PROVA DE RETRACAO DO COAGULO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,73<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
819,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 60; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.02.049-5 - PROVA DE RETRACAO DO COAGULO<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 61; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
31<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.027-9 - DOSAGEM DE COLESTEROL HDL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.500,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,51<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5.265,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 62; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.027-9 - DOSAGEM DE COLESTEROL HDL A FRAÇÃO HDL DO COLESTEROL É PROTETORA CONTRA DOENÇA ARTERIAL CORONARIANA SEGUNDO GRANDE NÚMERO DE ESTUDOS POPULACIONAIS, PORTANTO, AVALIA O RISCO DE DOENÇA ATEROSCLERÓTICA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 63; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
32<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.028-7 - DOSAGEM DE COLESTEROL LDL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.500,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,51<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5.265,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 64; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.028-7 - DOSAGEM DE COLESTEROL LDL A FRAÇÃO LDL DO COLESTEROL ESTÁ ASSOCIADO AO RISCO AUMENTADO DA DOENÇA ARTERIAL CORONARIANA. AS LIPOPROTEÍNAS DE BAIXA DENSIDADE SÃO AS PRINCIPAIS PROTEÍNAS DE TRANSPORTE DO COLESTEROL. SEUS NÍVEIS TAMBÉM SE ELEVAM NA SÍNDROME NEFRÓTICA, HIPOTIREOIDISMO E ICTERÍCIA OBSTRUTIVA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 65; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
33<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.029-5 - DOSAGEM DE COLESTEROL TOTAL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.500,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.775,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 66; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.029-5 - DOSAGEM DE COLESTEROL TOTAL CONSISTE NO EXAME DE SANGUE SIMPLES QUE MEDE OS NÍVEIS DE COLESTEROL NO ORGANISMO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 67; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
34<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.012-1 - DOSAGEM DE COMPLEMENTO C3<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.287,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 68; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.012-1 - DOSAGEM DE COMPLEMENTO C3 CONSISTE NA QUANTIFICAÇÃO DA FRAÇÃO C3, QUE É UM DOS COMPONENTES PRINCIPAIS DO SISTEMA COMPLEMENTO E ATUA NA RESPOSTA IMUNOLÓGICA HUMORAL E É ATIVADA PELA VIA CLÁSSICA E ALTERNATIVA. UTILIZADA NA AVALIAÇÃO DAS GLOMERULONEFRITES, LES E CRIOGLOBULINEMIA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 69; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
35<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.013-0 - DOSAGEM DE COMPLEMENTO C4<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.287,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 70; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.013-0 - DOSAGEM DE COMPLEMENTO C4 CONSISTE NA QUANTIFICAÇÃO DA FRAÇÃO C4, QUE É UM DOS COMPONENTES DO SISTEMA COMPLEMENTO, ATUA NA RESPOSTA IMUNOLÓGICA HUMORAL E PARTICIPA SOMENTE DA VIA CLÁSSICA DE ATIVAÇÃO. UTILIZADA NA AVALIAÇÃO DE ESTADOS INFLAMATÓRIOS, PROCESSOS MALIGNOS, NAS DOENÇAS POR IMUNOCOMPLEXOS E NAS DEFICIÊNCIAS CONGÊNITAS<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 71; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
36<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.02.054-1 - TESTE DIRETO DE ANTIGLOBULINA HUMANA (TAD)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,73<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
122,85<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 72; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.02.054-1 - TESTE DIRETO DE ANTIGLOBULINA HUMANA (TAD) CONSISTE NA IDENTIFICAÇÃO DIRETA DE IMUNOGLOBULINA E OU COMPLEMENTO LIGADO A MEMBRANA DA HEMÁCIA. ESTA INDICADO PARA ACOMPANHAMENTO DE QUADROS DE SENSIBILIZAÇÃO QUE TENHAM OCORRIDO IN VIVO DEVIDO A MECANISMOS AUTÓLOGOS OU ALOGENEICOS. O VALOR DO PROCEDIMENTO INCLUI INSUMOS NECESSÁRIOS A SUA EXECUÇÃO<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 73; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
37<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.12.009-0 - TESTE INDIRETO DE ANTIGLOBULINA HUMANA (TIA)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,73<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
122,85<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 74; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.12.009-0 - TESTE INDIRETO DE ANTIGLOBULINA HUMANA (TIA) CONSISTE NA PESQUISA A DE ANTICORPOS SERICOS IRREGULARES DIFERENTES DE ANTI A E ANTI B EM PACIENTES INCLUINDO UMA ETAPA COM A UTILIZACAO DE REAGENTE CONTENDO ANTIGLOBULINA HUMANA POLI OU MONO ESPECIFICO. A INDICACAO E DETECTAR IN VITRO A EXPOSICAO E SENSIBILIZACAO A ANTIGENOS DE GRUPOS SANGUINEOS QUE TENHA OCORRIDO POR TRANSFUSAO ANTERIOR OU GESTACAO E TAMBEM A INVESTIGACAO DE SUSPEITA DE REACOES TRANSFUSIONAIS. O VALOR DO PROCEDIMENTO INCLUI OS INSUMOS NECESSARIOS A SUA EXECUCAO<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 75; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
38<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.013-6 - DOSAGEM DE CORTISOL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
9,86<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
739,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 76; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.013-6 - DOSAGEM DE CORTISOL CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR CORTISOL, HORMÔNIO SECRETADO PELO CÓRTEX DA ADRENAL, ESSENCIAL PARA O METABOLISMO E FUNÇÕES IMUNOLÓGICAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 77; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
39<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.031-7 - DOSAGEM DE CREATININA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
120,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
222,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 78; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.031-7 - DOSAGEM DE CREATININA A CREATININA É O PRODUTO DE DEGRADAÇÃO DA CREATINA E SUA DOSAGEM É ÚTIL NA AVALIAÇÃO E NO MONITORAMENTO DA FUNÇÃO EXCRETORA RENAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 79; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
40<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.032-5 - DOSAGEM DE CREATINOFOSFOQUINASE (CPK)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,68<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
276,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 80; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.032-5 - DOSAGEM DE CREATINOFOSFOQUINASE (CPK) A CREATINOFOSFOQUINASE É UMA ENZIMA ENCONTRADA PRINCIPALMENTE NA MUSCULATURA ESTRIADA, CÉREBRO E CORAÇÃO. É UM MARCADOR SENSÍVEL, MAS INESPECÍFICO, DE LESÃO MIOCÁRDICA. NÍVEIS ELEVADOS SÃO ENCONTRADOS, POR EXEMPLO, NO INFARTO AGUDO DO MIOCÁRDIO, NA DISTROFIA MUSCULAR E NO EXERCÍCIO FÍSICO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 81; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
41<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.08.008-0 - CULTURA DE BACTÉRIAS PARA IDENTIFICAÇÃO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
450,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5,62<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.529,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 82; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.08.008-0 - CULTURA DE BACTÉRIAS PARA IDENTIFICAÇÃO CONSISTE NO EXAME REALIZADO A PARTIR DA COLETA DE UMA AMOSTRA BIOLÓGICA, QUE É PREPARADA EM UM MEIO DE CULTURA ESPECIAL PARA QUE AS BACTÉRIAS CRESÇAM E SEJAM IDENTIFICADAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 83; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
42<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.08.012-9 - CULTURA PARA BACTÉRIAS ANAEROBICAS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,25<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.537,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 84; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.08.012-9 - CULTURA PARA BACTÉRIAS ANAEROBICAS CONSISTE NO EXAME PARA DIAGNÓSTICO DAS INFECÇÕES CAUSADAS POR MICRORGANISMOS ANAERÓBIOS. A CULTURA ESPECÍFICA PARA ANAERÓBIOS É INDICADA EM INFECÇÕES INTRA-ABDOMINAIS, ABSCESSOS FECHADOS, INFECÇÕES EM SÍTIOS PROFUNDOS, LÍQUIDOS CAVITÁRIOS NOBRES OU EM INFECÇÕES SECUNDÁRIAS A MORDEDURAS E AINDA NA AVALIAÇÃO DE FALHA TERAPÊUTICA NA VIGÊNCIA DE TERAPIA ANTIMICROBIANA SEM COBERTURA PARA ANAERÓBIOS, PRESENÇA DE GÁS NA LESÃO, PRESENÇA DE GRÂNULOS EM DRENAGEM PURULENTA. AS AMOSTRAS DEVEM SER PROTEGIDAS DO CONTATO COM OXIGÊNIO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 85; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
43<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.08.013-7 - CULTURA PARA IDENTIFICACAO MORFOLÓGICA DE FUNGOS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4,19<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
314,25<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 86; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.08.013-7 - CULTURA PARA IDENTIFICACAO MORFOLÓGICA DE FUNGOS SEMEADURA DE AMOSTRA CLÍNICA EM MEIO DE CULTURA PARA VERIFICAÇÃO DE CRESCIMENTO E IDENTIFICAÇÃO MORFOLÓGICA PRIMÀRIA DE FUNGOS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 87; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
44<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.007-4 - DETERMINACAO DE CURVA GLICEMICA CLASSICA (5 DOSAGENS)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.500,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 88; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.007-4 - DETERMINACAO DE CURVA GLICEMICA CLASSICA (5 DOSAGENS) É UTILIZADA NO DIAGNOSTICO DE DIABETES EM PACIENTES NOS QUAIS A GLICEMIA DE JEJUM NÃO FOI ESCLARECEDORA ENTRE 100 E 125 MG/DL. O EXAME COMPREENDE DOSAGENS SERIADAS DE GLICOSE (BASAL,30,60,90 E 120 MINUTOS) APOS ESTIMULO COM 75 GRAMAS DE GLICOSE POR VIA ORAL OU CONFORME SOLICITAÇÃO MEDICA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 89; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.014-4 - DOSAGEM DE DEHIDROEPIANDROSTERONA (DHEA)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
30,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11,25<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
337,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 90; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.014-4 - DOSAGEM DE DEHIDROEPIANDROSTERONA (DHEA) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR DEHIDROEPIANDROSTERONA, ESTERÓIDE PRECURSOR DA SÍNTESE DE TESTOSTERONA, PRODUZIDO EM GRANDE PARTE PELO CÓRTEX DA SUPRA-RENAL E TAMBÉM PELAS GÔNODAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 91; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
46<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.037-6 - DOSAGEM DE DESIDROGENASE LATICA (ISOENZIMAS FRACIONADAS)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,68<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
276,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 92; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.037-6 - DOSAGEM DE DESIDROGENASE LATICA (ISOENZIMAS FRACIONADAS) CONSISTE NO EXAME LABORATORIAL QUE AVALIA AMOSTRAS BIOLÓGICAS, COMO SANGUE, URINA, FEZES OU TECIDOS, PARA DETECTAR DOENÇAS. SÃO ENZIMAS QUE CATALISAM A CONVERSÃO DE LACTATO A PIRUVATO E SÃO LIBERADAS EM QUADROS DE SOFRIMENTO DOS TECIDOS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 93; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
47<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.12.002-3 - DETERMINACAO DIRETA E REVERSA DE GRUPO ABO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,37<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
205,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 94; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.12.002-3 - DETERMINACAO DIRETA E REVERSA DE GRUPO ABO CONSISTE NA DETERMINACAO DOS ANTIGENOS DO SISTEMA ABO DE GRUPOS SANGUINEOS NA MEMBRANA DA HEMACIA E DO ANTICORPO CORRESPONDENTE NO PLASMA OU SORO DO INDIVIDUO EM TESTE. PODE SER REALIZADO PELO METODO EM TUBO FASE SOLIDA OU MICROPLACA DE ACORDO COM A ESTRATEGIA DE EXECUCAO DO ESTABELECIMENTO. O VALOR DO PROCEDIMENTO INCLUI OS INSUMOS NECESSARIOS A SUA EXECUCAO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 95; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
48<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.072-4 - ELETROFORESE DE PROTEINAS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
30,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4,42<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
132,60<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 96; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.072-4 - ELETROFORESE DE PROTEINAS ELETROFORESE É UMA TÉCNICA LABORATORIAL USADA PARA SEPARAR OS GRUPOS DE PROTEÍNAS DO SORO. A ELETROFORESE DE PROTEÍNAS É UTILIZADA NA TRIAGEM DE ANORMALIDADES DAS PROTEÍNAS SÉRICAS. AS PRINCIPAIS FRAÇÕES PROTEICAS, DE ACORDO COM A ELETROPOSITIVIDADE SÃO AS SEGUINTES: ALBUMINA, ALFA 1 GLOBULINA, ALFA 2 GLOBULINA, BETAGLOBULINA E GAMAGLOBULINA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 97; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
49<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.046-6 - PESQUISA DE ANTICORPOS ANTIESPERMATOZOIDES<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
15,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
9,70<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
145,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 98; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.046-6 - PESQUISA DE ANTICORPOS ANTIESPERMATOZOIDES CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTIESPERMATOZOIDES NO SORO OU PLASMA. UTILIZADO COMO MÉTODO AUXILIAR NO DIAGNÓSTICO E ACOMPANHAMENTO DA INFERTILIDADE MASCULINA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 99; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
50<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.016-0 - DOSAGEM DE ESTRADIOL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,15<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.522,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 100; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.016-0 - DOSAGEM DE ESTRADIOL CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR ESTROGÊNIO, HORMÔNIO MAIS ATIVO E MAIS IMPORTANTE NA MULHER EM IDADE REPRODUTIVA, COM VALORES MAIS ALTOS NO PICO OVULATÓRIO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 101; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
51<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.059-8 - PESQUISA DE ANTICORPOS ANTINUCLEO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.574,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 102; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.059-8 - PESQUISA DE ANTICORPOS ANTINUCLEO CONSISTE EM UM TESTE POR IMUNOFLUORENCÊNCIA INDIRETA, PARA DETECÇÃO DE ANTICORPOS ANTINUCLEARES NO SORO UTILIZADO PARA O DIAGNÓSTICO E ACOMPANHAMENTO DE DOENÇAS IMUNOMEDIADAS E AUTOIMUNES.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 103; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
52<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.12.008-2 - PESQUISA DE FATOR RH (INCLUI D FRACO)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,37<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
205,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 104; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: CONSISTE NA DETERMINACAO DE SITIOS ANTIGENICOS NA MEMBRANA DA HEMACIA PARA O ANTIGENO D DO SISTEMA RH DE GRUPOS SANGUINEOS EM PACIENTES. PODE SER UTILIZADO METODO EM TUBO FASE SOLIDA OU MICROPLACA DE ACORDO COM A ESTRATEGIA TECNICA DO ESTABELECIMENTO. CONTEMPLA A DEFINICAO DA CARACTERISTICA D FRACO QUANDO O TESTE INICIALMENTE FOR ENCONTRADO COMO RH NEGATIVO. O VALOR DO PROCEDIMENTO INCLUI OS INSUMOS NECESSARIOS A SUA EXECUCAO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 105; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
53<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.038-4 - DOSAGEM DE FERRITINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
15,59<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4.677,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 106; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.038-4 - DOSAGEM DE FERRITINA A DOSAGEM DE FERRITINA REFLETE O NÍVEL DE ESTOQUE CELULAR DE FERRO. PORTANTO, É UTILIZADO NO DIAGNÓSTICO E SEGUIMENTO DE ANEMIAS FERROPRIVAS E HEMOCROMATOSE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 107; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
54<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.039-2 - DOSAGEM DE FERRO SERICO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,51<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.053,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 108; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.039-2 - DOSAGEM DE FERRO SERICO A DOSAGEM DE FERRO SÉRICO É ÚTIL NO DIAGNÓSTICO DIFERENCIAL DE ANEMIAS, HEMOCROMATOSE E HEMOSSIDEROSE. ENCONTRA-SE NÍVEIS BAIXOS NA ANEMIA FERROPRIVA, GLOMERULOPATIAS, MENSTRUAÇÃO E FASES INICIAIS DE REMISSÃO DA ANEMIA PERNICIOSA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 109; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
55<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.042-2 - DOSAGEM DE FOSFATASE ALCALINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,01<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
301,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 110; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.042-2 - DOSAGEM DE FOSFATASE ALCALINA A FOSFATASE ALCALINA POSSUI DUAS ISOENZIMAS. UMA DELAS É DE ORIGEM HEPÁTICA E AVALIA DE MANEIRA SIGNIFICATIVA OS CASOS DE OBSTRUÇÃO BILIAR, A OUTRA É DE ORIGEM ÓSSEA E AVALIA AS DOENÇAS QUE AFETAM A ATIVIDADE OSTEOBLÁSTICA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 111; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
56<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.043-0 - DOSAGEM DE FOSFORO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
277,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 112; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.043-0 - DOSAGEM DE FOSFORO A DOSAGEM DE FÓSFORO É IMPORTANTE PARA A AVALIAÇÃO DO BALANÇO CÁLCIO/FÓSFORO NO ORGANISMO E PARA O MONITORAMENTO DA INSUFICIÊNCIA RENAL CRÔNICA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 113; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
57<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.023-3 - DOSAGEM DE HORMONIO FOLICULO-ESTIMULANTE (FSH)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
7,89<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.367,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 114; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.023-3 - DOSAGEM DE HORMONIO FOLICULO-ESTIMULANTE (FSH) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR HORMÔNIO FOLÍCULO ESTIMULANTE, QUE NA MULHER, ESTIMULA OS FOLÍCULOS OVARIANOS E, NO HOMEM, A ESPERMATOGÊNESE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 115; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
58<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.046-5 - DOSAGEM DE GAMA-GLUTAMIL-TRANSFERASE (GAMA GT)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,51<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
526,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 116; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.046-5 - DOSAGEM DE GAMA-GLUTAMIL-TRANSFERASE (GAMA GT) A GAMA GT É UM MARCADOR SENSÍVEL DE COLESTASE HEPATOBILIAR E DE USO DO ÁLCOOL. TENDE A SE ELEVAR EM DOENÇAS HEPÁTICAS E PANCREÁTICAS. A LIBRAÇÃO DE GAMA GT NO SORO REFLETE O EFEITO TÓXICO DO ÁLCOOL E OUTRAS DROGAS NA ESTRUTURA MICROSSOMAL NAS CÉLULAS HEPÁTICAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 117; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
59<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.047-3 - DOSAGEM DE GLICOSE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.250,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4.162,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 118; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.047-3 - DOSAGEM DE GLICOSE A DOSAGEM DE GLICOSE, TAMBÉM CHAMADA DE GLICEMIA, É UTILIZADA NO DIAGNÓSTICO E NO MONITORAMENTO DO DIABETES MELLITUS E NOS DISTÚRBIOS DA HOMEOSTASE GLICÊMICA. ALÉM DISSO, É ÚTIL NO RASTREAMENTO DO DIABETES GESTACIONAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 119; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
60<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.08.015-3 - HEMOCULTURA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11,49<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.723,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 120; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.08.015-3 - HEMOCULTURA CONSISTE NO EXAME DE SANGUE REALIZADO COM O OBJETIVO DE ISOLAR E IDENTIFICAR MICRORGANISMOS NA CORRENTE SANGUÍNEA, PESQUISANDO BACTÉRIAS NO SANGUE ATRAVÉS DO USO DE MEIOS DE CULTURA ESPECÍFICOS, POSSIBILITANDO IDENTIFICAR A BACTÉRIA CAUSADORA DA INFECÇÃO E A QUAL ANTIBIÓTICO É SENSÍVEL QUANDO ASSOCIADO AO ANTIBIOGRAMA.A COLETA DE SANGUE ESTÁ INDICADA QUANDO OCORRE PICOS DE FEBRE<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 121; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
61<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.050-3 - DOSAGEM DE HEMOGLOBINA GLICOSILADA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.500,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
7,86<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11.790,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 122; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.050-3 - DOSAGEM DE HEMOGLOBINA GLICOSILADA A DOSAGEM DE HEMOGLOBINA GLICOSILADA É UTILIZADA PARA O MONITORAMENTO DE PACIENTES DIABÉTICOS E, TAMBÉM, O DIAGNÓSTICO INICIAL, JÁ QUE REFLETE A GLICEMIA MÉDIA DOS ÚLTIMOS 90 A 120 DIAS. APRESENTA ELEVADO VALOR PREDITIVO POSITIVO PARA AS COMPLICAÇÕES CLÍNICAS DIABÉTICAS E APRESENTA BOA CORRELAÇÃO COM OS NÍVEIS DECISÓRIOS DE GLICOSE PLASMÁTICA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 123; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
62<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.02.038-0 - HEMOGRAMA COMPLETO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3.000,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4,11<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
12.330,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 124; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.02.038-0 - HEMOGRAMA COMPLETO CONSISTE NA CONTAGEM DE: ERITROCITOS, LEUCOCITOS (GLOBAL E DIFERENCIAL), PLAQUETAS, DOSAGEM DE HEMOGLOBINA, HEMATOCRITO, DETERMINACAO DOS INDICES HEMATIMETRICOS E AVALIACAO DE ESFREGACO SANGUINEO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 125; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
63<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.080-6 - PESQUISA DE ANTICORPOS IGG CONTRA O VIRUS DA HEPATITE A -IGG<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.782,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 126; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.080-6 - PESQUISA DE ANTICORPOS IGG CONTRA O VIRUS DA HEPATITE A (ANTI-HAV-IGG) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-HVA DA CLASSE IGG NO SORO. UTILIZADO NO DIAGNÓSTICO DIFERENCIAL DE HEPATITES. A PRESENÇA DE ANTICORPOS ANTI-HVA IGG INDICA CONTATO PASSADO COM O VÍRUS DA HEPATITE A.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 127; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
64<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.091-1 - PESQUISA DE ANTICORPOS IGM CONTRA O VIRUS DA HEPATITE A -IGM<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.782,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 128; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.091-1 - PESQUISA DE ANTICORPOS IGM CONTRA O VIRUS DA HEPATITE A (ANTI-HAV-IGM) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-HVA DA CLASSE IGM NO SORO. A PRESENÇA DE ANTICORPOS ANTI-HVA IGM INDICA FASE AGUDA DA INFECÇÃO PELO VÍRUS DA HEPATITE A.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 129; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
65<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.064-4 - PESQUISA DE ANTICORPOS CONTRA ANTIGENO DO VIRUS DA HEPATITE B<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.782,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 130; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.064-4 - PESQUISA DE ANTICORPOS CONTRA ANTIGENO DO VIRUS DA HEPATITE B (ANTI-HBE) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-HBE NO SORO. O ANTICORPO SURGE NA RECUPERAÇÃO DA INFECÇÃO AGUDA, APÓS O ANTÍGENO HBEAG NÃO MAIS SER DETECTADO. EM UM PORTADOR DO HBV, UM RESULTADO POSITIVO DE ANTI-HBE USUALMENTE INDICA INATIVIDADE DO VÍRUS E BAIXA INFECCIOSIDADE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 131; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
66<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.063-6 - PESQUISA DE AC. CONTRA AG DE SUPERFICIE DO VIRUS DA HEPATITE B<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.782,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 132; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.063-6 - PESQUISA DE ANTICORPOS CONTRA ANTIGENO DE SUPERFICIE DO VIRUS DA HEPATITE B (ANTI-HBS) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-HBS NO SORO. UTILIZADO NO DIAGNÓSTICO DIFERENCIAL, ACOMPANHAMENTO E PROGNÓSTICO DE INFECÇÃO POR HEPATITE B, NA AVALIAÇÃO DE IMUNIDADE EM INDIVÍDUOS SUJEITOS A RISCO DE CONTÁGIO COM HBV E NA AVALIAÇÃO DE EFICÁCIA DO PROTOCOLO DE IMUNIZAÇÃO PARA HBV.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 133; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
67<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.098-9 - PESQUISA DE ANTIGENO E DO VIRUS DA HEPATITE B (HBEAG)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.782,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 134; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.098-9 - PESQUISA DE ANTIGENO E DO VIRUS DA HEPATITE B (HBEAG) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DO ANTÍGENO ''E'' DO VÍRUS DA HEPATITE B NO SORO. UTILIZADO NO DIAGNÓSTICO DIFERENCIAL, ACOMPANHAMENTO<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 135; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
68<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.089-0 - PESQUISA DE AC. IGM CONTRA AG. CENTRAL DO VIRUS DA HEPATITE B<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.782,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 136; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.089-0 - PESQUISA DE ANTICORPOS IGM CONTRA ANTIGENO CENTRAL DO VIRUS DA HEPATITE B (ANTI-HBC-IGM) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-HBC DA CLASSE IGM NO SORO. UTILIZADO NO DIAGNÓSTICO DE HEPATITE B. A PRESENÇA DE ANTICORPOS IGM INDICA UM PROCESSO DE INFECÇÃO RECENTE OU AGUDA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 137; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
69<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.022-5 - DOSAGEM DE HORMONIO DE CRESCIMENTO (HGH)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,21<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
459,45<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 138; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.022-5 - DOSAGEM DE HORMONIO DE CRESCIMENTO (HGH) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR HORMÔNIO DO CRESCIMENTO - HGH, UM POLIPEPTÍDEO PRODUZIDO NA HIPÓFISE ANTERIOR, SUA PRINCIPAL AÇÃO NA INFÂNCIA É A DE PROMOVER O CRESCIMENTO. NO ADULTO, INFLUENCIA O METABOLISMO LIPÍDICO E ÓSSEO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 139; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
70<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.024-1 - DOSAGEM DE HORMONIO LUTEINIZANTE (LH)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
90,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
8,97<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
807,30<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 140; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.024-1 - DOSAGEM DE HORMONIO LUTEINIZANTE (LH) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR HORMÔNIO LUTEINIZANTE, ESTIMULADOR DAS CÉLULAS INTERSTICIAIS, NOS OVÁRIOS E NOS TESTÍCULOS. NO SEXO FEMININO, SEU GRANDE AUMENTO NO MEIO DO CICLO INDUZ A OVULAÇÃO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 141; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
71<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.015-6 - DOSAGEM DE IMUNOGLOBULINA A (IGA)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
120,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.059,20<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 142; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.015-6 - DOSAGEM DE IMUNOGLOBULINA A (IGA) CONSISTE NA DOSAGEM DE IMUNOGLOBULINA A, QUE CONSTITUI 15 A 20% DAS IMUNOGLOBULINAS SÉRICAS. COMPREENDE A MAIOR CLASSE DE ANTICORPOS EM SECREÇÕES, COMO SALIVA, LÁGRIMA, LEITE, SECREÇÕES GASTROINTESTINAIS E DO TRATO RESPIRATÓRIO. UTILIZADA NA AVALIAÇÃO DAS INFECÇÕES CRÔNICAS, IMUNODEFICIÊNCIA PRIMÁRIA E MIELOMA MÚLTIPLO TIPO IGA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 143; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
72<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.016-4 - DOSAGEM DE IMUNOGLOBULINA E (IGE)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
120,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
9,25<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.110,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 144; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.016-4 - DOSAGEM DE IMUNOGLOBULINA E (IGE) CONSISTE NA DOSAGEM DE IMUNOGLOBULINA E, IMUNOGLOBULINA QUE TEM UM PAPEL CENTRAL NA PATOGÊNESE DAS REAÇÕES DE HIPERSENSIBILIDADE IMEDIATA. UTILIZADA NA AVALIAÇÃO DAS REAÇÕES ALÉRGICAS, COMO RINITE ALÉRGICA, ASMA E DERMATITE ATÓPICA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 145; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
73<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.026-8 - DOSAGEM DE INSULINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,17<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.525,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 146; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.026-8 - DOSAGEM DE INSULINA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE INSULINA, UM PEPTÍDEO SINTETIZADO PELAS CÉLULAS BETA DAS ILHOTAS DE LANGERHANS DO PÂNCREAS, E SUA SECREÇÃO É CONTROLADA PELOS NÍVEIS DE GLICEMIA, ESTÍMULOS NERVOSOS E HORMONAIS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 147; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
74<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.09.030-2 - PROVA DO LATEX PARA PESQUISA DO FATOR REUMATOIDE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,89<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
283,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 148; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.09.030-2 - PROVA DO LATEX PARA PESQUISA DO FATOR REUMATOIDE CONSISTE NO TESTE IMUNOLÓGICO RÁPIDO E SIMPLES QUE AJUDA A DIAGNOSTICAR A ARTRITE REUMATOIDE (AR), NELE É ADICIONADO UM REAGENTE ESPECÍFICO A UMA AMOSTRA DE SANGUE PARA VERIFICAR SE HÁ FORMAÇÃO DE GRUMOS, O QUE INDICA A PRESENÇA DE FR. OUTRAS DOENÇAS ASSOCIADAS AO FR ENDOCARDITE BACTERIANA SUBAGUDA, MALÁRIA, SÍFILIS, TUBERCULOSE, HEPATITE CRÔNICA, HANSENÍASE (LEPRA), LEISHIMANIOSE, LINFOMAS, MONONUCLEOSE INFECCIOSA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 149; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.036-8 - DOSAGEM DE DESIDROGENASE LATICA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
60,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,68<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
220,80<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 150; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.036-8 - DOSAGEM DE DESIDROGENASE LATICA A DESIDROGENASE LÁTICA É UMA ENZIMA QUE CATALIZA A CONVERSÃO DE LACTATO A PIRUVATO E É LIBERADA EM QUADROS DE INJÚRIA TISSULAR. PORTANTO A ELEVAÇÃO DOS NÍVEIS DE DESIDROGENASE LÁTICA OCORRE, POR EXEMPLO, EM NEOPLASIAS, HIPÓXIA, CARDIOPATIAS, INFLAMAÇÕES, HIPOTIREOIDISMO, HEPATITES, PANCREATITE E OBSTRUÇÃO INTESTINAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 151; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
76<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.075-0 - PESQUISA DE ANTICORPOS IGG ANTILEISHMANIAS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
60,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
9,25<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
555,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 152; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.075-0 - PESQUISA DE ANTICORPOS IGG ANTILEISHMANIAS CONSISTE EM UM TESTE, PARA DETECTAR A PRESENÇA DE ANTICORPO IGG NO SORO. UTILIZADO NO DIAGNÓSTICO DE LEISHMANIOSE NA FORMA VISCERAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 153; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
77<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.086-5 - PESQUISA DE ANTICORPOS IGM ANTILEISHMANIAS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
60,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
600,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 154; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.086-5 - PESQUISA DE ANTICORPOS IGM ANTILEISHMANIAS CONSISTE EM UM TESTE, PARA DETECTAR A PRESENÇA DE ANTICORPO IGM NO SORO. UTILIZADO NO DIAGNÓSTICO DE LEISHMANIOSE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 155; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
78<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.04.009-7 - PESQUISA DE LEUCOCITOS NAS FEZES<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
30,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,65<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
49,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 156; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.04.009-7 - PESQUISA DE LEUCOCITOS NAS FEZES CONSISTE NA PESQUISA DE LEUCÓCITOS NAS FEZES, POR MICROSCOPIA DIRETA OU COLORAÇÃO ESPECIFICA. UTILIZADA NA AVALIAÇÃO DE INFECÇÕES BACTERIANAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 157; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
79<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.055-4 - DOSAGEM DE LIPASE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,25<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
168,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 158; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.055-4 - DOSAGEM DE LIPASE A LIPASE É UMA ENZIMA PRODUZIDA MAJORITARIAMENTE NO PÂNCREAS E É UM MARCADOR PRIMORDIAL DE DOENÇA PANCREÁTICA. OS NÍVEIS DE LIPASE FICAM ELEVADOS, PRINCIPALMENTE, NA PANCREATITE AGUDA E, FREQUENTEMENTE, NA PANCREATITE CRÔNICA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 159; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
80<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.056-2 - DOSAGEM DE MAGNESIO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,01<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
301,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 160; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.056-2 - DOSAGEM DE MAGNESIO O MAGNÉSIO É UM DOS CÁTIONS MAIS ABUNDANTES NO ORGANISMO HUMANO, ATUANDO COMO COFATOR ESSENCIAL PARA ENZIMAS LIGADAS À RESPIRAÇÃO CELULAR, À GLICÓLISE E AO TRANSPORTE DE OUTROS CÁTIONS. ALÉM DISSO, O MAGNÉSIO É ESSENCIAL PARA A PRESERVAÇÃO DA ESTRUTURA MOLECULAR DO DNA, DO RNA E DOS RIBOSSOMOS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 161; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
81<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.05.009-2 - DOSAGEM DE MICROALBUMINA NA URINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
120,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
8,12<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
974,40<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 162; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.05.009-2 - DOSAGEM DE MICROALBUMINA NA URINA CONSISTE NA DOSAGEM PARA DETECÇÃO DA PRESENÇA DE PEQUENAS QUANTIDADES DE ALBUMINAS URINÁRIAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 163; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
82<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.060-0 - DOSAGEM DE POTASSIO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
450,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
832,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 164; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.060-0 - DOSAGEM DE POTASSIO A DOSAGEM DE POTÁSSIO É ÚTIL NA AVALIAÇÃO DO EQUILÍBRIO HIDROELETROLÍTICO E ACIDOBÁSICO. A MONITORIZAÇÃO DO POTÁSSIO É UTILIZADA NO ACOMPANHAMENTO DE PACIENTES EM TERAPIA COM DIURÉTICOS, EM NEFROPATIAS, NA CETOACIDOSE DIABÉTICA, NO MANEJO DA HIDRATAÇÃO PARENTERAL E NA INSUFICIÊNCIA HEPÁTICA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 165; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
83<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.029-2 - DOSAGEM DE PROGESTERONA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,22<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.533,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 166; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.029-2 - DOSAGEM DE PROGESTERONA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE PROGESTERONA, HORMÔNIO ESTERÓIDE PRODUZIDO PELO OVÁRIO, PLACENTA E CÓRTEX ADRENAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 167; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
84<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.030-6 - DOSAGEM DE PROLACTINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,15<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.522,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 168; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.030-6 - DOSAGEM DE PROLACTINA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE PROLACTINA, HORMÔNIO PROTEICO SECRETADO PELA HIPÓFISE ANTERIOR E PLACENTA<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 169; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
85<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.008-3 - DETERMINAÇÃO QUANTITATIVA DE PROTEÍNA C REATIVA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
9,25<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.775,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 170; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.008-3 - DETERMINAÇÃO QUANTITATIVA DE PROTEÍNA C REATIVA CONSISTE NA QUANTIFICAÇÃO DA PROTEÍNA C REATIVA, QUE É UMA DAS PROTEÍNAS DE FASE AGUDA, CONSIDERADA UM MARCADOR SENSÍVEL NO MONITORAMENTO DAS DOENÇAS INFLAMATÓRIAS E REUMÁTICAS EM GERAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 171; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
86<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.062-7 - DOSAGEM DE PROTEINAS TOTAIS E FRACOES<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
277,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 172; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.062-7 - DOSAGEM DE PROTEINAS TOTAIS E FRACOES A ALBUMINA É A PROTEÍNA MAIS ABUNDANTE NO PLASMA E SUA FUNÇÃO PRIMÁRIA É MANTER A PRESSÃO COLOIDOSMÓTICA DO PLASMA. EM CONDIÇÕES NORMAIS, ESPERA-SE ENCONTRAR UMA RAZÃO ALBUMINA/GLOBULINA MAIOR OU IGUAL A 1.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 173; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
87<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.05.011-4 - DOSAGEM DE PROTEINAS (URINA DE 24 HORAS)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,04<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
306,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 174; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.05.011-4 - DOSAGEM DE PROTEINAS (URINA DE 24 HORAS) CONSISTE NA DOSAGEM DE PROTEÍNAS URINÁRIAS PARA AVALIAÇÃO DE DOENÇAS RENAIS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 175; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
88<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.010-5 - DOSAGEM DE ANTIGENO PROSTATICO ESPECÍFICO (PSA)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.250,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
16,42<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
36.945,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 176; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.010-5 - DOSAGEM DE ANTIGENO PROSTATICO ESPECÍFICO (PSA) CONSISTE NA DOSAGEM DE ANTÍGENO PROSTÁTICO ESPECIFICO (PSA), QUE É UMA PROTEASE PRODUZIDA QUASE EXCLUSIVAMENTE PELAS CÉLULAS EPITELIAIS DO TECIDO PROSTÁTICO. UTILIZADO NA AVALIAÇÃO DO CÂNCER DE PRÓSTATA, NA HIPERTROFIA PROSTÁTICA BENIGNA E NA PROSTATITE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 177; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
89<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.027-6 - DOSAGEM DE PARATORMONIO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
30,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
43,13<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.293,90<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 178; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.027-6 - DOSAGEM DE PARATORMONIO CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE PARATORMÔNIO, HORMÔNIO POLIPEPTÍDICO SECRETADO PELAS GLÂNDULAS PARATIREOIDES QUE TEM PRINCIPAL FUNÇÃO A MANUTENÇÃO DA HOMEOSTASE DO FÓSFORO E CÁLCIO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 179; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
90<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.081-4 - PESQUISA DE ANTICORPOS IGG CONTRA O VIRUS DA RUBEOLA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.574,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 180; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.081-4 - PESQUISA DE ANTICORPOS IGG CONTRA O VIRUS DA RUBEOLA CONSISTE EM UM TESTE IMUNOENZIMÁTICO, PARA DETECTAR A PRESENÇA DE ANTICORPOS DA CLASSE IGG. UTILIZADO NA AVALIAÇÃO PRÉ-NATAL DE MULHERES.A PRESENÇA DE ANTICORPOS DA CLASSE IGG INDICA IMUNIDADE ADQUIRIDA NATURAL OU ARTIFICIALMENTE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 181; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
91<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.092-0 - PESQUISA DE ANTICORPOS IGM CONTRA O VIRUS DA RUBEOLA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
17,16<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.574,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 182; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.092-0 - PESQUISA DE ANTICORPOS IGM CONTRA O VIRUS DA RUBEOLA CONSISTE EM UM TESTE IMUNOENZIMÁTICO, PARA DETECTAR A PRESENÇA DE ANTICORPOS DA CLASSE IGM. UTILIZADO NA AVALIAÇÃO PRÉ-NATAL DE MULHERES.UTILIZADO NO DIAGNÓSTICO DE INFECÇÃO AGUDA DE RUBÉOLA<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 183; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
92<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.04.014-3 - PESQUISA DE SANGUE OCULTO NAS FEZES<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
60,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,65<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
99,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 184; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.04.014-3 - PESQUISA DE SANGUE OCULTO NAS FEZES CONSISTE EM UM TESTE POR VÁRIOS MÉTODOS E TÉCNICAS PARA DETECTAR A PRESENÇA DE HEMOGLOBINA NAS FEZES.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 185; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
93<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.063-5 - DOSAGEM DE SODIO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
450,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
832,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 186; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.063-5 - DOSAGEM DE SODIO O SÓDIO É O PRINCIPAL CÁTION EXTRACELULAR, ALÉM DISSO É O DETERMINANTE PRIMORDIAL DA OSMOLARIDADE CELULAR. ALGUNS FATORES REGULAM A HOMEOSTASIA DO BALANÇO DO SÓDIO, TAIS COMO, ALDOSTERONA E HORMÔNIO ANTIDIURÉTICO. A DOSAGEM DE SÓDIO É ÚTIL NA AVALIAÇÃO DOS DISTÚRBIOS HIDROELETROLÍTICOS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 187; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
94<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.087-3 - PESQUISA DE ANTICORPOS IGM ANTITOXOPLASMA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.391,25<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 188; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.087-3 - PESQUISA DE ANTICORPOS IGM ANTITOXOPLASMA CONSISTE EM UM TESTE IMUNOENZIMÁTICO, PARA DETECTAR A PRESENÇA DE ANTICORPOS DA CLASSE IGM.UTILIZADO NO DIAGNOSTICO DA FASE AGUDA DA INFECÇÃO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 189; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
95<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.076-8 - PESQUISA DE ANTICORPOS IGG ANTITOXOPLASMA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
75,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
16,97<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.272,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 190; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.076-8 - PESQUISA DE ANTICORPOS IGG ANTITOXOPLASMA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS IGG NO SORO. UTILIZADO NO DIAGNOSTICO E ACOMPANHAMENTO DE TOXOPLASMOSE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 191; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
96<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.033-0 - DOSAGEM DE SULFATO DE HIDROEPIANDROSTERONA (DHEAS)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
90,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
13,11<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.179,90<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 192; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.033-0 - DOSAGEM DE SULFATO DE HIDROEPIANDROSTERONA (DHEAS) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE SULFATO DE DEHIDROEPIANDROSTERONA, UM ESTERÓIDE ABUNDANTE E SINTETIZADO NAS ADRENAIS. MARCADOR DA FUNÇÃO ADRENAL CORTICAL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 193; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
97<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.05.001-7 - ANÁLISE DE CARACTERES FISICOS, ELEMENTOS E SEDIMENTO DA URINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3.000,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,70<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11.100,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 194; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.05.001-7 - ANÁLISE DE CARACTERES FISICOS, ELEMENTOS E SEDIMENTO DA URINA CONSISTEM NA ANÁLISE QUALITATIVA, QUANTITATIVA DE ELEMENTOS ANORMAIS (FÍSICOS E QUÍMICOS) E DO SEDIMENTO URINÁRIO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 195; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
98<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.039-0 - DOSAGEM DE TRIIODOTIRONINA (T3)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
600,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
8,71<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5.226,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 196; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.039-0 - DOSAGEM DE TRIIODOTIRONINA (T3) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE TRIIODOTIRONINA, HORMÔNIO PRODUZIDO PRIMARIAMENTE PELA DESIODAÇÃO DO T4, E TAMBÉM SECRETADO DIRETAMENTE PELA GLÂNDULA TIREÓIDE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 197; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
99<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.001-2 - DETERMINAÇÃO DE ÍNDICE DE TIROXINA LIVRE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
450,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
12,54<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5.643,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 198; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.001-2 - DETERMINAÇÃO DE ÍNDICE DE TIROXINA LIVRE CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DA FRAÇÃO LIVRE DA TIROXINA, HORMÔNIO PRODUZIDO PELA GLÂNDULA TIREOIDE COM FUNÇÃO DE CONTROLAR O METABOLISMO DO ORGANISMO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 199; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
100<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.037-3 - DOSAGEM DE TIROXINA (T4)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
600,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
8,76<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5.256,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 200; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.037-3 - DOSAGEM DE TIROXINA (T4) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE TIROXINA, PRINCIPAL HORMÔNIO SECRETADO PELA GLÂNDULA TIREÓIDE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 201; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
101<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.038-1 - DOSAGEM DE TIROXINA LIVRE (T4 LIVRE)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
450,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11,60<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5.220,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 202; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.038-1 - DOSAGEM DE TIROXINA LIVRE (T4 LIVRE) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE TIROXINA LIVRE, FRAÇÃO RESPONSÁVEL PELO EFEITO METABÓLICO DO HORMÔNIO TIREOIDIANO, PRINCIPAL RESPONSÁVEL PELO FEEDBACK COM O TSH.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 203; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
102<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.02.048-7 - PROVA DE CONSUMO DE PROTROMBINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4,11<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
616,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 204; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.02.048-7 - PROVA DE CONSUMO DE PROTROMBINA<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 205; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
103<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.02.007-0 - DETERMINAÇÃO DE TEMPO DE COAGULAÇÃO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,73<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
409,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 206; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.02.007-0 - DETERMINAÇÃO DE TEMPO DE COAGULAÇÃO A DETERMINAÇÃO DE TEMPO DE COAGULAÇÃO AVALIA A ATIVIDADE DOS FATORES QUE PARTICIPAM DO PROCESSO INTRÍNSECO DA COAGULAÇÃO. RESULTADOS NORMAIS, NO ENTANTO, PODEM SER OBTIDOS EM PACIENTES COM DEFICIÊNCIA LEVE OU MODERADA DE UM DESSES FATORES. O RESULTADO MOSTRA O TEMPO GASTO PARA A HOMEOSTASIA COMPLETA DO SANGUE QUANDO COLHIDO E COLOCADO EM CONDIÇÕES PADRÃO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 207; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
104<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.034-9 - DOSAGEM DE TESTOSTERONA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,43<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3.129,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 208; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.034-9 - DOSAGEM DE TESTOSTERONA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE TESTOSTERONA, ESTEROIDE ANDROGÊNICO SECRETADO PRINCIPALMENTE NOS TESTÍCULOS, SENDO O PRINCIPAL HORMÔNIO MASCULINO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 209; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
105<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.036-5 - DOSAGEM DE TIREOGLOBULINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
90,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
15,35<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.381,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 210; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.036-5 - DOSAGEM DE TIREOGLOBULINA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE TIREOGLOBULINA, GLICOPROTEÍNA PRODUZIDA PELAS CÉLULAS TIROIDIANAS, SENDO O MAIOR COMPONENTE DO COLÓIDE INFRAFOLICULAR DA GLÂNDULA TIREÓIDE.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 211; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
106<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.066-0 - DOSAGEM DE TRANSFERRINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
225,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4,12<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
927,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 212; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.066-0 - DOSAGEM DE TRANSFERRINA A TRANSFERRINA É UMA GLICOPROTEÍNA SINTETIZADA NO FÍGADO. É A PRINCIPAL PROTEÍNA PLASMÁTICA TRANSPORTADORA DE FERRO, SENDO QUE OCORREM VARIAÇÕES EM SUAS CONCENTRAÇÕES EM RESPOSTA A DEFICIÊNCIA DE FERRO E EM DOENÇAS CRÔNICAS. A DOSAGEM DE TRANSFERRINA É UTILIZADA NO DIAGNÓSTICO E NO MONITORAMENTO DE ANEMIAS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 213; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
107<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.067-8 - DOSAGEM DE TRIGLICERIDEOS<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.350,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3,51<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4.738,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 214; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.067-8 - DOSAGEM DE TRIGLICERIDEOS A DOSAGEM DE TRIGLICERÍDEOS, EM CONJUNTO COM A DOSAGEM DO COLESTEROL, É UTILIZADA NA AVALIAÇÃO DO RISCO CÁRDIACO. OS TRIGLICERÍDEOS SÃO PRODUZIDOS NO FÍGADO E SÃO TRANSPORTADOS NO SANGUE POR VLDL E LDL.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 215; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
108<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.120-9 - DOSAGEM DE TROPONINA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
225,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
9,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.025,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 216; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.120-9 - DOSAGEM DE TROPONINA CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE TROPONINAS CARDÍACAS, QUE CONSTITUEM UM IMPORTANTE MARCADOR NO DIAGNÓSTICO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 217; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
109<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.06.025-0 - DOSAGEM DE HORMONIO TIREOESTIMULANTE (TSH)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
750,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
8,96<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
6.720,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 218; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.06.025-0 - DOSAGEM DE HORMONIO TIREOESTIMULANTE (TSH) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECTAR HORMÔNIO TIREOESTIMULANTE (TSH) UMA GLICOPROTEÍNA SECRETADA PELA ADENOHIPÓFISE QUE TEM COMO PRINCIPAL FUNÇÃO ESTIMULAR A TIREÓIDE A LIBERAR T3 E T4.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 219; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
110<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.02.013-4 - DETERMINAÇÃO DE TEMPO DE TROMBOPLASTINA PARCIAL ATIVADA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
5,77<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
865,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 220; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.02.013-4 - DETERMINAÇÃO DE TEMPO DE TROMBOPLASTINA PARCIAL ATIVADA (TTP ATIVADA) A DETERMINAÇÃO DE TEMPO DE TROMBOPLASTINA PARCIAL ATIVADA (TTP ATIVADA) NORMALMENTE MEDE A VIA INTRÍNSECA DA COAGULAÇÃO. É INDICADA NOS CASOS DE SUSPEITA DE DEFICIÊNCIA DE FATORES DA VIA INTRÍNSECA DA COAGULAÇÃO, ANTES DE SEREM REALIZADAS INTERVENÇÕES CIRÚRGICAS, E NO CONTROLE DE TERAPÊUTICA ANTICOAGULANTE PELA HEPARINA. A DETERMINAÇÃO DE TEMPO DE TROMBOPLASTINA PARCIAL ATIVADA (TTP ATIVADA) NORMALMENTE MEDE A VIA INTRÍNSECA DA COAGULAÇÃO. É INDICADA NOS CASOS DE SUSPEITA DE DEFICIÊNCIA DE FATORES DA VIA INTRÍNSECA DA COAGULAÇÃO, ANTES DE SEREM REALIZADAS INTERVENÇÕES CIRÚRGICAS, E NO CONTROLE DE TERAPÊUTICA ANTICOAGULANTE PELA HEPARINA. O TEMPO DE TROMBOPLASTINA PARCIAL CORRESPONDE AO TEMPO GASTO PARA OCORRER A COAGULAÇÃO DO PLASMA RECALCIFICADO EM PRESENÇA DE CEFALINA<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 221; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
111<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.069-4 - DOSAGEM DE UREIA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
450,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1,85<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
832,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 222; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.069-4 - DOSAGEM DE UREIA A UREIA É A PRINCIPAL FONTE DE EXCREÇÃO DO NITROGÊNIO, ORIGINA-SE DO METABOLISMO HEPÁTICO DAS PROTEÍNAS E É EXCRETADA NOS RINS. DESSA FORMA, A UREIA ESTÁ DIRETAMENTE RELACIONADA À FUNÇÃO METABÓLICA HEPÁTICA E À FUNÇÃO RENAL. SUA CONCENTRAÇÃO PODE VARIAR, POR EXEMPLO, COM A DIETA E COM A HIDRATAÇÃO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 223; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
112<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.111-0 - TESTE NÃO TREPONEMICO P/ DETECÇÃO DE SIFILIS PARA POPUL. GERAL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
225,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,83<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
636,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 224; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.111-0 - TESTE NÃO TREPONEMICO PARA DETECÇÃO DE SIFILIS PARA POPULAÇÃO GERAL (EXCETO GESTANTE, PARCEIRO OU PARCERIA) ENSAIOS IMUNOLÓGICOS DO TIPO: VDRL (VENERAL DISEASERECEARCH LABORATORY), RPR (RSPID TEST REAGIN), TRUST (TOLOIDIN REDUNHEATED SERUM TEST) OU USR (UNHEATED SERUM REAGIN) PARA DETECÇÃO DE ANTICORPOS NÃO TREPONÊMICOS. NÃO UTILIZAR ESTE CÓDIGO PARA GESTANTES E SUAS PARCERIAS SEXUAIS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 225; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
113<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.02.015-0 - DETERMINAÇÃO DE VELOCIDADE DE HEMOSSEDIMENTAÇÃO (VHS)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2,73<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
409,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 226; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.02.015-0 - DETERMINAÇÃO DE VELOCIDADE DE HEMOSSEDIMENTAÇÃO (VHS) A VELOCIDADE DE HEMOSSEDIMENTAÇÃO (VHS) É UM FENÔMENO NÃO ESPECÍFICO. ALÉM DISSO SUA DETERMINAÇÃO É CLINICAMENTE ÚTIL NAS DESORDENS ASSOCIADAS COM A PRODUÇÃO AUMENTADA DE PROTEÍNAS DE FASE AGUDA, EMBORA NÃO SEJA ESPECÍFICO. NA ARTRITE REUMATÓIDE E NA TUBERCULOSE, POR EXEMPLO, É UM ÍNDICE DE PROGRESSÃO DA DOENÇA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 227; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
114<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.070-8 - DOSAGEM DE VITAMINA B12<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
15,24<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4.572,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 228; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.070-8 - DOSAGEM DE VITAMINA B12 A VITAMINA B12 TEM PAPEL IMPORTANTE NA HEMATOPOIESE, NA FUNÇÃO NEURAL, NO METABOLISMO DO ÁCIDO FÓLICO E NA SÍNTESE ADEQUADA DE DNA. A ABSORÇÃO DE VITAMINA B12 É DEPENDENTE DA PRESENÇA DO FATOR INTRÍNSECO (SECRETADO PELA CÉLULAS PARIETAIS DO ESTÔMAGO).<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 229; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
115<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.01.076-7 - DOSAGEM DE 25 HIDROXIVITAMINA D<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
750,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
15,24<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
11.430,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 230; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.01.076-7 - DOSAGEM DE 25 HIDROXIVITAMINA D CONSISTE NA DOSAGEM SÉRICA DO COLECAL-CIFEROL OU 25-HIDROXIVITAMINA D, O METABÓLITO MAIS ATIVO DA VITAMINA D E DE MAIOR NÍVEL SÉRICO, PARA O DIAGNÓSTICO E MONITORIZAÇÃO TERAPÊUTICA DO RAQUITISMO E OSTEOMALÁCIA.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 231; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
116<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.07.035-2 - DOSAGEM DE ZINCO<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
225,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
15,65<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
3.521,25<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 232; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.07.035-2 - DOSAGEM DE ZINCO CONSISTE NA DOSAGEM DE ZINCO. ÚTIL NA AVALIAÇÃO DE EXPOSIÇÃO E INTOXICAÇÃO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 233; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
117<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.150-0 - PESQUISA LAB. DE AG DE HIV OU AC ANTI-HIV 1 OU 2 POPUL. GERAL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
100,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.000,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 234; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.150-0 - PESQUISA LABORATORIAL DE ANTÍGENOS DE HIV E/OU ANTICORPOS ANTI-HIV-1 OU ANTI-HIV-2 PARA POPULAÇÃO GERAL (EXCETO GESTANTE, PARCEIRO OU PARCERIA) CONSISTE EM UM IMUNOENSAIO (CLIA, ELISA, CMIA E OUTRAS VARIAÇÕES) PARA DETECTAR A PRESENÇA DE ANTICORPOS ANTI-HIV OU ANTÍGENOS DO HIV NO SORO OU PLASMA. NÃO UTILIZAR ESTE CÓDIGO PARA GESTANTES E SUAS PARCERIAS SEXUAIS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 235; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
118<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.151-9 - PESQUISA LAB. DE AG DE HIV OU AC ANTI-HIV 1 OU 2 GESTANTE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
100,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.000,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 236; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.151-9 - PESQUISA LABORATORIAL DE ANTÍGENOS DE HIV OU ANTICORPOS ANTI-HIV-1 OU ANTI-HIV-2 EM GESTANTE CONSISTE EM UM IMUNOENSAIO (CLIA, ELISA, CMIA E OUTRAS VARIAÇÕES) PARA DETECTAR A PRESENÇA DE ANTICORPOS ANTI-HIV OU ANTÍGENOS DO HIV NO SORO OU PLASMA DE GESTANTES.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 237; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
119<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.152-7 - PESQ LAB DE AG DE HIV OU AC ANTI-HIV 1 OU 2 EM PARC DE GESTANTE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
100,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.000,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 238; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.152-7 - PESQUISA LABORATORIAL DE ANTÍGENOS DE HIV OU ANTICORPOS ANTI-HIV-1 OU ANTI-HIV-2 EM PARCEIRO E PARCERIA DE GESTANTE CONSISTE EM UM IMUNOENSAIO (CLIA, ELISA, CMIA E OUTRAS VARIAÇÕES),PARA DETECTAR A PRESENÇA DE ANTICORPOS ANTI-HIV OU ANTÍGENOS DO HIV NO SORO OU PLASMA DE PARCERIAS SEXUAIS DE GESTANTES.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 239; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
120<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.141-1 - TESTE FTA-ABS TOTAL PARA DIAGNÓSTICO DA SÍFILIS P POPUL GERAL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
20,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
200,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 240; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.141-1 - TESTE FTA-ABS TOTAL PARA DIAGNÓSTICO DA SÍFILIS PARA POPULAÇÃO GERAL (EXCETO GESTANTE, PARCEIRO OU PARCERIA) ENSAIO IMUNOLÓGICO DO TIPO: TESTE DE ANTICORPOS TREPONÊMICOS FLUORESCENTES COM ABSORÇÃO (FTA-ABS) TOTAL (IGM E IGG). NÃO UTILIZAR ESTE CÓDIGO PARA GESTANTES E SUAS PARCERIAS SEXUAIS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 241; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
121<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.142-0 - TESTE FTA-ABS TOTAL PARA DIAGNÓSTICO DA SÍFILIS EM GESTANTE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
20,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
200,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 242; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.142-0 - TESTE FTA-ABS TOTAL PARA DIAGNÓSTICO DA SÍFILIS EM GESTANTE ENSAIO IMUNOLÓGICO EM GESTANTES DO TIPO: TESTE DE ANTICORPOS TREPONÊMICOS FLUORESCENTES COM ABSORÇÃO (FTA-ABS) TOTAL (IGM E IGG).<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 243; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
122<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.143-8 - TESTE FTA-ABS TOTAL PARA DIAG DA SÍFILIS EM PARC DA GESTANTE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
20,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
200,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 244; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.143-8 - TESTE FTA-ABS TOTAL PARA DIAGNÓSTICO DA SÍFILIS EM PARCEIRO OU PARCERIA DE GESTANTE ENSAIO IMUNOLÓGICO EM PARCERIAS SEXUAIS DE GESTANTES DO TIPO: TESTE DE ANTICORPOS TREPONÊMICOS FLUORESCENTES COM ABSORÇÃO (FTA-ABS) TOTAL (IGM E IGG).<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 245; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
123<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.141-1 - TESTE FTA-ABS TOTAL PARA DIAG DA SÍFILIS PARA POPULAÇÃO GERAL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
10,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
20,00<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
200,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 246; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.141-1 - TESTE FTA-ABS TOTAL PARA DIAGNÓSTICO DA SÍFILIS PARA POPULAÇÃO GERAL (EXCETO GESTANTE, PARCEIRO OU PARCERIA) ENSAIO IMUNOLÓGICO DO TIPO: TESTE DE ANTICORPOS TREPONÊMICOS FLUORESCENTES COM ABSORÇÃO (FTA-ABS) TOTAL (IGM E IGG). NÃO UTILIZAR ESTE CÓDIGO PARA GESTANTES E SUAS PARCERIAS SEXUAIS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 247; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
124<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.144-6 - PESQUISA LAB DE AG DE SPC DO VÍRUS DA HEPATITE B POP GERAL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
50,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
927,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 248; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.144-6 - PESQUISA LABORATORIAL DE ANTÍGENO DE SUPERFÍCIE DO VÍRUS DA HEPATITE B (HBSAG) PARA POPULAÇÃO GERAL (EXCETO GESTANTE, PARCEIRO OU PARCERIA) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DO ANTÍGENO DE SUPERFÍCIE DO VÍRUS DA HEPATITE B NO SORO. UTILIZADO NO DIAGNÓSTICO DIFERENCIAL, ACOMPANHAMENTO E PROGNÓSTICO DE INFECÇÃO POR HEPATITE B. NÃO UTILIZAR ESTE CÓDIGO PARA GESTANTES E SUAS PARCERIAS SEXUAIS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 249; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
125<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.145-4 - PESQUISA LAB DE AG DE SFC DO VÍRUS DA HEPATITE B EM GESTANTE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
50,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
927,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 250; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.145-4 - PESQUISA LABORATORIAL DE ANTÍGENO DE SUPERFÍCIE DO VÍRUS DA HEPATITE B (HBSAG) EM GESTANTE CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DO ANTÍGENO DE SUPERFÍCIE DO VÍRUS DA HEPATITE B NO SORO DE GESTANTES. UTILIZADO NO DIAGNÓSTICO DIFERENCIAL, ACOMPANHAMENTO E PROGNÓSTICO DE INFECÇÃO POR HEPATITE B<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 251; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
126<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.146-2 - PESQUISA LAB DE AG DE SFC DO VÍRUS DA HEPATITE B PARC GESTANTE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
50,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
927,50<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 252; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.146-2 - PESQUISA LABORATORIAL DE ANTÍGENO DE SUPERFÍCIE DO VÍRUS DA HEPATITE B (HBSAG) EM PARCEIRO OU PARCERIA DE GESTANTE CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DO ANTÍGENO DE SUPERFÍCIE DO VÍRUS DA HEPATITE B NO SORO DE PARCERIAS SEXUAIS DE GESTANTES. UTILIZADO NO DIAGNÓSTICO DIFERENCIAL, ACOMPANHAMENTO E PROGNÓSTICO DE INFECÇÃO POR HEPATITE B<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 253; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
127<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.147-0 - PESQUISA LAB DE AC CONTRA O VÍRUS DA HEPATITE C POPULAÇÃO GERAL<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
25,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
463,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 254; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.147-0 - PESQUISA LABORATORIAL DE ANTICORPOS CONTRA O VÍRUS DA HEPATITE C (ANTI-HCV) PARA POPULAÇÃO GERAL (EXCETO GESTANTE, PARCEIRO OU PARCERIA) CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-HCV NO SORO. UTILIZADO NO DIAGNÓSTICO DA HEPATITE C. NÃO UTILIZAR ESTE CÓDIGO PARA GESTANTES E SUAS PARCERIAS SEXUAIS.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 255; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
128<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.148-9 - PESQUISA LAB DE AC CONTRA O VÍRUS DA HEPATITE C EM GESTANTE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
25,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
463,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 256; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.148-9 - PESQUISA LABORATORIAL DE ANTICORPOS CONTRA O VÍRUS DA HEPATITE C (ANTI-HCV) EM GESTANTE CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-HCV NO SORO DE GESTANTES. UTILIZADO NO DIAGNÓSTICO DA HEPATITE C.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 257; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
129<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.03.149-7 - PESQUISA LAB DE AC CONTRA O VÍRUS DA HEPATITE C PARC GESTANTE<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
25,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18,55<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
463,75<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 258; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.03.149-7 - PESQUISA LABORATORIAL DE ANTICORPOS CONTRA O VÍRUS DA HEPATITE C (ANTI-HCV) EM PARCEIRO OU PARCERIA DE GESTANTE CONSISTE EM UM TESTE IMUNOENZIMÁTICO PARA DETECÇÃO DE ANTICORPOS ANTI-HCV NO SORO DE PARCERIAS SEXUAIS DE GESTANTES. UTILIZADO NO DIAGNÓSTICO DA HEPATITE C.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 259; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
130<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.02.08.001-3 - ANTIBIOGRAMA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
300,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
4,98<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.494,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 260; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.02.08.001-3 - ANTIBIOGRAMA<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 261; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
131<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.03.01.001-9 - EXAME CITOPATOLÓGICO CERVICO-VAGINAL/MICROFLORA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
600,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
13,72<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
8.232,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 262; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.03.01.001-9 - EXAME CITOPATOLÓGICO CERVICO-VAGINAL/MICROFLORA CONSISTE NA ANALISE MICROSCÓPICA DE MATERIAL COLETADO DO COLO DO ÚTERO. INDICADO PARA TODAS AS MULHERES COM VIDA SEXUAL ATIVA PARA DIAGNÓSTICO, DAS LESÕES PRE- NEOPLÁSICAS E CÂNCER DO COLO DO ÚTERO.<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 263; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
132<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.03.02.008-1 - EXAME ANATOMO-PATOLOGICO DO COLO UTERINO - BIOPSIA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
450,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
40,78<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
18.351,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 264; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.03.02.008-1 - EXAME ANATOMO-PATOLOGICO DO COLO UTERINO - BIOPSIA CONSISTE NO EXAME MACRO E MICROSCÓPICO DE MATERIAL OBTIDO POR BIOPSIA DO COLO UTERINO, INCLUSIVE PÓLIPO ENDOCERVICAL. O RESULTADO DO EXAME PODE, EM UMA MINORIA DE CASOS, NÃO SER DE MALIGNIDADE. OS EXAMES SERÃO REALIZADOS CONFORME CID CONSTANTE NA TABELA NO SIGTAP - SISTEMA DE GERENCIAMENTO DA TABELA DE PROCEDIMENTOS, MEDICAMENTOS E OPM (ÓRTESES, PRÓTESES E MATERIAIS ESPECIAIS) DO SUS<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 265; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
133<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.03.02.006-5 - EXAME ANATOMOPATOLOGICO DE MAMA - BIOPSIA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
1.500,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
45,83<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
68.745,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 266; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.03.02.006-5 - EXAME ANATOMOPATOLOGICO DE MAMA - BIOPSIA CONSISTE NO EXAME MACRO E MICROSCOPIO DE MATERIAL OBTIDO POR PUNCAO DE MAMA POR AGULHA GROSSA OU POR BIOPSIA/EXERESE CIRURGICA, PARA DIAGNOSTICO DEFINITIVO DE MODULO MAMARIO. O RESULTADO DO EXAME PATOLÓGICO PODE, EM UMA MINORIA DE CASOS, NÃO SER DE MALIGNIDADE. OS EXAMES SERÃO REALIZADOS CONFORME CID CONSTANTE NA TABELA NO SIGTAP - SISTEMA DE GERENCIAMENTO DA TABELA DE PROCEDIMENTOS, MEDICAMENTOS E OPM (ÓRTESES, PRÓTESES E MATERIAIS ESPECIAIS) DO SUS<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 267; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
134<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.03.01.003-5 - EXAME DE CITOLOGIA (EXCETO CERVICO-VAGINAL E DE MAMA)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
2.850,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
20,96<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
59.736,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 268; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.03.01.003-5 - EXAME DE CITOLOGIA (EXCETO CERVICO-VAGINAL E DE MAMA) CONSISTE NO EXAME CITOPATOLÓGICO DE ESFREGACOS, FIXADOS E CORADOS, PROVENIENTES DA ASPIRAÇÃO DE LÍQUIDOS BIOLÓGICOS, OU TECIDOS RASPADOS, LAVADOS, IMPRINT E CELL BLOCK. OS EXAMES SERÃO REALIZADOS CONFORME CID CONSTANTE NA TABELA NO SIGTAP - SISTEMA DE GERENCIAMENTO DA TABELA DE PROCEDIMENTOS, MEDICAMENTOS E OPM (ÓRTESES, PRÓTESES E MATERIAIS ESPECIAIS) DO SUS<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 269; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
135<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.03.01.004-3 - EXAME CITOPATOLOGICO DE MAMA<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
750,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
35,34<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
26.505,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 270; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.03.01.004-3 - EXAME CITOPATOLOGICO DE MAMA CONSISTE NO EXAME CITOPATOLOGICO DE MATERIAL DE DESCARGA PAPILAR OU OBTIDO POR PUNCAO DE NODULO MAMARIO, ESTA REALIZADA POR ASPIRACAO ATRAVES DE SERINGA ACOPLADA A AGULHA FINA. OS EXAMES SERÃO REALIZADOS CONFORME CID CONSTANTE NA TABELA NO SIGTAP - SISTEMA DE GERENCIAMENTO DA TABELA DE PROCEDIMENTOS, MEDICAMENTOS E OPM (ÓRTESES, PRÓTESES E MATERIAIS ESPECIAIS) DO SUS<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 271; height: 1.0pt;">
<td width="44" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
136<o:p></o:p>
</td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
02.03.02.004-9 - IMUNOHISTOQUIMICA DE NEOPLASIAS MALIGNAS (POR MARCADOR)<o:p></o:p>
</td>
<td width="62" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
150,00<o:p></o:p>
</td>
<td width="73" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Unidade<o:p></o:p>
</td>
<td width="61" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
131,52<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
19.728,00<o:p></o:p>
</td>
</tr>
<tr style="mso-yfti-irow: 272; height: 1.0pt;">
<td width="44" nowrap="nowrap" style="width: 32.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="327" valign="bottom" style="width: 245.55pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
PROCEDIMENTO: 02.03.02.004-9 - IMUNOHISTOQUIMICA DE NEOPLASIAS MALIGNAS (POR MARCADOR) CONSISTE NA UTILIZACAO DE ANTICORPOS MONOCLONAIS (MARCADORES) PARA DETERMINAR A ORIGEM TECIDUAL E O DIAGNOSTICO DEFINITIVO DE NEOPLASIAS MALIGNAS INESPECIFICADAS AO EXAME HISTOPATOLOGICO. MAXIMO DE 06 MARCADORES POR PACIENTE.NÃO SE APLICA A RECEPTORES HORMONAIS TUMORAIS. OS EXAMES SERÃO REALIZADOS CONFORME CID CONSTANTE NA TABELA NO SIGTAP - SISTEMA DE GERENCIAMENTO DA TABELA DE PROCEDIMENTOS, MEDICAMENTOS E OPM (ÓRTESES, PRÓTESES E MATERIAIS ESPECIAIS) DO SUS<o:p></o:p>
</td>
<td width="62" nowrap="nowrap" style="width: 46.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="73" nowrap="nowrap" style="width: 54.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="61" nowrap="nowrap" style="width: 45.4pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
<td width="95" nowrap="nowrap" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;"></td>
</tr>
<tr style="mso-yfti-irow: 273; mso-yfti-lastrow: yes; height: 1.0pt;">
<td width="567" colspan="5" style="width: 425.0pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
Valor Total:<o:p></o:p>
</td>
<td width="95" style="width: 70.9pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 3.5pt 0cm 3.5pt; height: 1.0pt;">
485.513,00<o:p></o:p>
</td>
</tr>
</tbody>
</table>
</div>
<o:p> </o:p>Canindé-CE 06 de janeiro de 2026.<o:p></o:p>
Suellen Cavalcante de Sousa Vale Secretária Executiva<o:p></o:p>
Consórcio Público de Saúde da Microrregião de Canindé<o:p></o:p>

Quebrar página antes (PDF)

Evitar quebra dentro (PDF)

Status

Cancelar

Importar em lote

Cole vários documentos (HTML ou texto). Separe cada um com uma linha contendo apenas três hifens: ---.

Edição

Secretaria

Status

Ex.: DOC1...
---
DOC2...
---
DOC3...

Publicações

Mostrando 1– 6 de 374 publicações

ID	Título	Secretaria	Ordem	Status
18	(sem título) —	CÂMARA MUNICIPAL DE CANINDÉ	1	Publicado	Ver (web) PDF Editar
27	(sem título) —	CÂMARA MUNICIPAL DE CANINDÉ	1	Publicado	Ver (web) PDF Editar
42	(sem título) —	CÂMARA MUNICIPAL DE CANINDÉ	1	Publicado	Ver (web) PDF Editar
73	(sem título) —	CÂMARA MUNICIPAL DE CANINDÉ	1	Publicado	Ver (web) PDF Editar
90	(sem título) —	CÂMARA MUNICIPAL DE CANINDÉ	1	Publicado	Ver (web) PDF Editar
95	(sem título) —	CÂMARA MUNICIPAL DE CANINDÉ	1	Publicado	Ver (web) PDF Editar